$CCRD
CoreCard Corp

2021 Q1 Form 10-Q Financial Statement

#000143774921010685 Filed on May 04, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $8.912M $7.893M
YoY Change 12.91% 13.31%
Cost Of Revenue $4.429M $3.506M
YoY Change 26.33% 38.36%
Gross Profit $4.483M $4.387M
YoY Change 2.19% -1.02%
Gross Profit Margin 50.3% 55.58%
Selling, General & Admin $917.0K $1.090M
YoY Change -15.87% 72.47%
% of Gross Profit 20.46% 24.85%
Research & Development $2.101M $918.0K
YoY Change 128.87% -23.18%
% of Gross Profit 46.87% 20.93%
Depreciation & Amortization $855.0K $300.0K
YoY Change 185.0% 66.67%
% of Gross Profit 19.07% 6.84%
Operating Expenses $3.018M $2.008M
YoY Change 50.3% 9.91%
Operating Profit $1.465M $2.379M
YoY Change -38.42% -8.68%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $75.00K $136.0K
YoY Change -44.85% 33.33%
Pretax Income $1.407M $1.465M
YoY Change -3.96% -46.36%
Income Tax $367.0K $418.0K
% Of Pretax Income 26.08% 28.53%
Net Earnings $1.040M $1.047M
YoY Change -0.67% -49.47%
Net Earnings / Revenue 11.67% 13.26%
Basic Earnings Per Share $0.12 $0.12
Diluted Earnings Per Share $0.12 $0.12
COMMON SHARES
Basic Shares Outstanding 8.899M 8.925M
Diluted Shares Outstanding 8.933M 9.022M

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $31.00M $30.54M
YoY Change 1.51% 36.04%
Cash & Equivalents $31.00M $30.54M
Short-Term Investments
Other Short-Term Assets $1.059M $979.0K
YoY Change 8.17% -10.35%
Inventory
Prepaid Expenses
Receivables $5.069M $8.083M
Other Receivables $220.0K $0.00
Total Short-Term Assets $37.35M $39.60M
YoY Change -5.68% 45.42%
LONG-TERM ASSETS
Property, Plant & Equipment $7.555M $2.414M
YoY Change 212.97% 67.06%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.788M $0.00
YoY Change -100.0%
Other Assets $4.111M $3.428M
YoY Change 19.92% 109.41%
Total Long-Term Assets $16.48M $10.70M
YoY Change 54.06% 59.63%
TOTAL ASSETS
Total Short-Term Assets $37.35M $39.60M
Total Long-Term Assets $16.48M $10.70M
Total Assets $53.83M $50.30M
YoY Change 7.02% 48.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $781.0K $372.0K
YoY Change 109.95% 36.76%
Accrued Expenses $262.0K $293.0K
YoY Change -10.58% 130.71%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.403M $9.411M
YoY Change -21.34% 84.02%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.965M $2.250M
YoY Change 31.78% 204.05%
Total Long-Term Liabilities $3.783M $2.522M
YoY Change 50.0% 238.98%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.403M $9.411M
Total Long-Term Liabilities $3.783M $2.522M
Total Liabilities $11.19M $11.93M
YoY Change -6.26% 103.7%
SHAREHOLDERS EQUITY
Retained Earnings $31.05M $22.89M
YoY Change 35.62% 76.81%
Common Stock $16.09M $15.60M
YoY Change 3.13% 2.49%
Preferred Stock
YoY Change
Treasury Stock (at cost) $4.351M
YoY Change
Treasury Stock Shares $114.5K
Shareholders Equity $42.65M $38.37M
YoY Change
Total Liabilities & Shareholders Equity $53.83M $50.30M
YoY Change 7.02% 48.23%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $1.040M $1.047M
YoY Change -0.67% -49.47%
Depreciation, Depletion And Amortization $855.0K $300.0K
YoY Change 185.0% 66.67%
Cash From Operating Activities -$2.326M $5.693M
YoY Change -140.86% 53.62%
INVESTING ACTIVITIES
Capital Expenditures $1.496M $539.0K
YoY Change 177.55% 381.25%
Acquisitions
YoY Change
Other Investing Activities -$532.0K -$1.000M
YoY Change -46.8% 100.0%
Cash From Investing Activities -$2.028M -$1.539M
YoY Change 31.77% 151.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $2.712M $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$2.605M
YoY Change
NET CHANGE
Cash From Operating Activities -$2.326M 5.693M
Cash From Investing Activities -$2.028M -1.539M
Cash From Financing Activities -$2.605M
Net Change In Cash -$6.955M 4.123M
YoY Change -268.69% 30.76%
FREE CASH FLOW
Cash From Operating Activities -$2.326M $5.693M
Capital Expenditures $1.496M $539.0K
Free Cash Flow -$3.822M $5.154M
YoY Change -174.16% 43.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000320340
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8882350
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
INTELLIGENT SYSTEMS CORP
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2021Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value for the class
CY2021Q1 dei Trading Symbol
TradingSymbol
ins
CY2021Q1 ins Increase Decrease In Deferred Revenue Current
IncreaseDecreaseInDeferredRevenueCurrent
-528000
CY2020Q1 ins Increase Decrease In Deferred Revenue Current
IncreaseDecreaseInDeferredRevenueCurrent
3422000
CY2021Q1 ins Increase Decrease In Deferred Revenue Noncurrent
IncreaseDecreaseInDeferredRevenueNoncurrent
101000
CY2020Q1 ins Increase Decrease In Deferred Revenue Noncurrent
IncreaseDecreaseInDeferredRevenueNoncurrent
-8000
CY2021Q1 ins Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
73000
CY2021Q1 ins Noncash Interest Income
NoncashInterestIncome
37000
CY2020Q1 ins Noncash Interest Income
NoncashInterestIncome
32000
CY2021Q1 ins Notes And Interest Receivable Current
NotesAndInterestReceivableCurrent
220000
CY2020Q4 ins Notes And Interest Receivable Current
NotesAndInterestReceivableCurrent
CY2021Q1 ins Notes And Interest Receivable Noncurrent
NotesAndInterestReceivableNoncurrent
3030000
CY2020Q4 ins Notes And Interest Receivable Noncurrent
NotesAndInterestReceivableNoncurrent
2681000
CY2021Q1 ins Number Of Stockbased Compensation Plans In Effect
NumberOfStockbasedCompensationPlansInEffect
3
CY2021Q1 ins Operating Lease Rightofuse Asset And Lease Liability
OperatingLeaseRightofuseAssetAndLeaseLiability
3950000
CY2020Q4 ins Operating Lease Rightofuse Asset And Lease Liability
OperatingLeaseRightofuseAssetAndLeaseLiability
2889000
CY2021Q1 ins Payments For Notes And Interest Receivable
PaymentsForNotesAndInterestReceivable
550000
CY2020Q1 ins Payments For Notes And Interest Receivable
PaymentsForNotesAndInterestReceivable
1000000
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
781000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
714000
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5069000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3270000
CY2021Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1383000
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
954000
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
262000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
321000
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-136000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-140000
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
15999000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37956000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
37956000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26415000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
31001000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
30538000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6955000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
15836000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
62000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
57000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
57000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
62000
CY2021Q1 us-gaap Assets
Assets
53833000
CY2020Q4 us-gaap Assets
Assets
57025000
CY2021Q1 us-gaap Assets Current
AssetsCurrent
37349000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
42489000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31001000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4123000
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8996868
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8929368
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8882350
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8885797
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
90000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
89000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1044000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1016000
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
4429000
CY2020Q1 us-gaap Cost Of Revenue
CostOfRevenue
3506000
CY2021Q1 us-gaap Costmethod Investments Other Than Temporary Impairment
CostmethodInvestmentsOtherThanTemporaryImpairment
CY2020Q1 us-gaap Costmethod Investments Other Than Temporary Impairment
CostmethodInvestmentsOtherThanTemporaryImpairment
1009000
CY2021Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
818000
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
818000
CY2021Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
794000
CY2020Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1322000
CY2021Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
101000
CY2020Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
855000
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
302000
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4000
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-31000
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1543000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1901000
CY2021Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
122000
CY2020Q1 us-gaap Equity Method Investments
EquityMethodInvestments
0
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
880000
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1058000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1407000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1465000
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-133000
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-41000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
367000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
418000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
67000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-31000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1799000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-676000
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
211000
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
140000
CY2021Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-358000
CY2020Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1091000
CY2021Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-204000
CY2020Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
74000
CY2021Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-2239000
CY2020Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
236000
CY2021Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
33000
CY2020Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
6000
CY2021Q1 us-gaap Investment Income Net
InvestmentIncomeNet
-133000
CY2020Q1 us-gaap Investment Income Net
InvestmentIncomeNet
-1050000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4255000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
399000
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
53833000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
57025000
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
7403000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
785000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1009000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
903000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10062000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1086000
CY2021Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
3783000
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2812000
CY2021Q1 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2021Q1 us-gaap Long Term Investments
LongTermInvestments
1788000
CY2020Q4 us-gaap Long Term Investments
LongTermInvestments
1921000
CY2021Q1 us-gaap Marketing Expense
MarketingExpense
37000
CY2020Q1 us-gaap Marketing Expense
MarketingExpense
32000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2605000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2028000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1539000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2326000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5693000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
1040000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
1047000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1465000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
2379000
CY2021Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
284000
CY2020Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
160000
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2864000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1994000
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
284000
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
160000
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.043
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.038
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y182D
CY2021Q1 us-gaap Other Assets Current
OtherAssetsCurrent
1059000
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1263000
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4111000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3020000
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-31000
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
4000
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
4000
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-31000
CY2021Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2640000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4850000
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
75000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
136000
CY2021Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2712000
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1496000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
539000
CY2021Q1 us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
18000
CY2020Q1 us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
107000
CY2020Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
CY2021Q1 us-gaap Profit Loss
ProfitLoss
1040000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
1047000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7555000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6914000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2101000
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
918000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
31045000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
30005000
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
8912000
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
7893000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
57000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
62000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1389970
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
59000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
17.35
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
1173570
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
45000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
14.83
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y146D
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P7Y73D
CY2021Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
67500
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
107000
CY2021Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
649000000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
37289000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
38367000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
44151000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
42647000
CY2021Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
114518
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
43571
CY2021Q1 us-gaap Treasury Stock Value
TreasuryStockValue
4351000
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1639000
CY2021Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
2712000
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8933090
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9021754
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8899011
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8924988

Files In Submission

Name View Source Status
R24.htm Edgar Link pending
0001437749-21-010685-index-headers.html Edgar Link pending
0001437749-21-010685-index.html Edgar Link pending
0001437749-21-010685.txt Edgar Link pending
0001437749-21-010685-xbrl.zip Edgar Link pending
ex_244441.htm Edgar Link pending
ex_244442.htm Edgar Link pending
ex_244443.htm Edgar Link pending
ex_245335.htm Edgar Link pending
ex_245336.htm Edgar Link pending
ex_245337.htm Edgar Link pending
ex_245338.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
ins-20210331.xml Edgar Link completed
ins-20210331.xsd Edgar Link pending
ins-20210331_cal.xml Edgar Link unprocessable
ins-20210331_def.xml Edgar Link unprocessable
ins-20210331_lab.xml Edgar Link unprocessable
ins-20210331_pre.xml Edgar Link unprocessable
ins20210331_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending